CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 136 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 12.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $179,000 | -45.3% | 67,211 | -11.0% | 0.00% | -50.0% |
| Q4 2021 | $327,000 | -19.5% | 75,513 | -5.4% | 0.00% | 0.0% |
| Q3 2021 | $406,000 | -25.1% | 79,853 | -6.7% | 0.00% | -20.0% |
| Q2 2021 | $542,000 | -16.1% | 85,629 | +2.4% | 0.01% | -16.7% |
| Q1 2021 | $646,000 | +18.1% | 83,629 | +0.2% | 0.01% | 0.0% |
| Q4 2020 | $547,000 | -13.7% | 83,493 | +1.1% | 0.01% | -40.0% |
| Q1 2020 | $634,000 | -17.2% | 82,601 | -10.4% | 0.01% | +66.7% |
| Q4 2019 | $766,000 | – | 92,233 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,803,700 | $25,130,000 | 0.91% |
| Altium Capital Management LP | 663,800 | $2,874,000 | 0.79% |
| Rubric Capital Management LP | 2,406,449 | $10,420,000 | 0.49% |
| RTW INVESTMENTS, LP | 6,029,700 | $26,109,000 | 0.38% |
| Orbimed Advisors | 3,214,509 | $13,919,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 152,345 | $660,000 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 980,085 | $4,244,000 | 0.12% |
| Point72 Asset Management, L.P. | 6,303,025 | $27,292,000 | 0.11% |
| Sender Co & Partners, Inc. | 40,720 | $176,000 | 0.09% |
| Manteio Capital LLC | 15,067 | $65,000 | 0.08% |